Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50

Thyroid

Volumn 8, Issue 1, 1998, Pages 63-69

  Venkataraman, Gopalakrishnan M ^b   Yatin, Mustafa ^b   Ain, Kenneth B ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; COMPLEMENTARY DNA; IODIDE; IODINE 125; LUCIFERASE; MESSENGER RNA; RADIOACTIVE IODINE; SODIUM IODIDE; THYROTROPIN;

ANIMAL CELL; ARTICLE; CERCOPITHECIDAE; CHILD; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CELL;

EID: 0031916456     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.63     Document Type: Article

References (24)

1. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-459.
2. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM 1996 Cloning of the human sodium iodide symporter. Biochem Biophys Res Comm 226:339-345.
3. Smanik PA, Ryu K-Y, Theil KS, Mazzaferri EL, Jhiang SM 1997 Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 138(8):3555-3558.
4. Gilbert SF, Migeon BR 1975 D-Valine as a selective agent for normal human and rodent epithelial cells in culture. Cell 5:11-17.
5. Kao WW-Y, Prockop DJ 1977 Proline analogue removes fibroblasts from cultured mixed cell populations. Nature 266:63-64.
6. Pályi I, Péter I, Daubner D, Vincze B, Lõrincz I 1993 Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101). Virchows Archiv B Cell Pathol 63:263-269.
7. Aim KB, Tofiq S, Taylor KD 1996 Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo. J Clin Endocrinol Metab 81(10): 3650-3653.
8. Ain KB, Taylor KD, Tofiq S, Venkataraman G 1997 Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82(6):1857-1862.
9. Ain KB, Taylor KD 1994 Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78(5):1097-1102.
10. Chomczynski P, Sacchi N 1987 Singlee step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Cheng S, Fockler C, Barnes WM, Higuchi R 1994 Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 91(12):5695-5699.
12. Frohman MA 1993 Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: Thermal RACE. Methods Enzymol 218:340-356.
13. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R 1989 A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J 8(9): 2537-2542.
14. Civitariale D, Castelli MP, Falasca P, Saiardi A 1993 Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol Endocrinol 7(12):1589-1595.
15. Francis-Lang H, Zannini M, De Felice M, Berlingieri MT, Fusco A, Di Lauro R 1992 Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol Cell Biol 12(12):5793-5800.
16. Santisteban P, Acebrón A, Polycarpou-Schwarz M, Di Lauro R 1992 Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinol 6(8):1310-1317.
17. Kadonaga JT, Coury AJ, Ladika, J, Tijian R 1988 Science 242:1566-1570.
18. Farr A, Roman A 1992 A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res 20(4):920.
19. Bucher P 1990 Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 212(4):563-578.
20. Bidey SP, Lambert A, Robertson WR 1988 Thyroid cell growth, differentiation and function in the FRTL-5 cell line: A survey. J Endocrinol 119:365-376.
21. Corliss CE 1976 Patten's Human Embryology: Elements of Clinical Development. McGraw-Hill Book Co, New York.
22. Achong DM, Oates E, Lee SL, Doherty FJ 1991 Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma. J Nucl Med 32(12):2275-2277.
23. van Herle AJ, Agatep ML, Padua III DN, Totanes TL, Canlapan DV, Van Herle HML, Juillard GJF 1990 Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA RO 82 W-1) in vitro. J Clin Endocrinol Metab 71(3):755-763.
24. Simon D, Köhrle J, Schmutzler C, Mainz K, Reiners C, Röher H-D 1996 Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basics and first clinical results. Exp Clin Endocrinol Diabetes 104(Suppl 4):13-15.